UniProt ID | SRP68_HUMAN | |
---|---|---|
UniProt AC | Q9UHB9 | |
Protein Name | Signal recognition particle subunit SRP68 | |
Gene Name | SRP68 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 627 | |
Subcellular Localization | Cytoplasm. Nucleus, nucleolus. | |
Protein Description | Signal-recognition-particle assembly has a crucial role in targeting secretory proteins to the rough endoplasmic reticulum membrane. SRP68 binds the 7S RNA, SRP72 binds to this complex subsequently. This ribonucleoprotein complex might interact directly with the docking protein in the ER membrane and possibly participate in the elongation arrest function.. | |
Protein Sequence | MAAEKQVPGGGGGGGSGGGGGSGGGGSGGGRGAGGEENKENERPSAGSKANKEFGDSLSLEILQIIKESQQQHGLRHGDFQRYRGYCSRRQRRLRKTLNFKMGNRHKFTGKKVTEELLTDNRYLLLVLMDAERAWSYAMQLKQEANTEPRKRFHLLSRLRKAVKHAEELERLCESNRVDAKTKLEAQAYTAYLSGMLRFEHQEWKAAIEAFNKCKTIYEKLASAFTEEQAVLYNQRVEEISPNIRYCAYNIGDQSAINELMQMRLRSGGTEGLLAEKLEALITQTRAKQAATMSEVEWRGRTVPVKIDKVRIFLLGLADNEAAIVQAESEETKERLFESMLSECRDAIQVVREELKPDQKQRDYILEGEPGKVSNLQYLHSYLTYIKLSTAIKRNENMAKGLQRALLQQQPEDDSKRSPRPQDLIRLYDIILQNLVELLQLPGLEEDKAFQKEIGLKTLVFKAYRCFFIAQSYVLVKKWSEALVLYDRVLKYANEVNSDAGAFKNSLKDLPDVQELITQVRSEKCSLQAAAILDANDAHQTETSSSQVKDNKPLVERFETFCLDPSLVTKQANLVHFPPGFQPIPCKPLFFDLALNHVAFPPLEDKLEQKTKSGLTGYIKGIFGFRS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MAAEKQVPGGGG ---CCCCCCCCCCCC | 52.44 | 23236377 | |
16 | Phosphorylation | GGGGGGGSGGGGGSG CCCCCCCCCCCCCCC | 37.22 | 29255136 | |
17 | Ubiquitination | GGGGGGSGGGGGSGG CCCCCCCCCCCCCCC | 41.88 | 22817900 | |
21 | Ubiquitination | GGSGGGGGSGGGGSG CCCCCCCCCCCCCCC | 26.79 | 22817900 | |
22 | Phosphorylation | GSGGGGGSGGGGSGG CCCCCCCCCCCCCCC | 37.22 | 29255136 | |
27 | Phosphorylation | GGSGGGGSGGGRGAG CCCCCCCCCCCCCCC | 37.22 | 29255136 | |
31 | Methylation | GGGSGGGRGAGGEEN CCCCCCCCCCCCCCC | 34.75 | 115917793 | |
33 | Ubiquitination | GSGGGRGAGGEENKE CCCCCCCCCCCCCCC | 22.81 | 22817900 | |
39 | Ubiquitination | GAGGEENKENERPSA CCCCCCCCCCCCCCC | 66.26 | 22817900 | |
39 (in isoform 1) | Ubiquitination | - | 66.26 | 21890473 | |
39 (in isoform 2) | Ubiquitination | - | 66.26 | 21890473 | |
48 | Phosphorylation | NERPSAGSKANKEFG CCCCCCCHHHHHHHH | 28.45 | 22817900 | |
49 | Ubiquitination | ERPSAGSKANKEFGD CCCCCCHHHHHHHHC | 55.87 | 21906983 | |
49 (in isoform 1) | Ubiquitination | - | 55.87 | 21890473 | |
49 (in isoform 2) | Ubiquitination | - | 55.87 | 21890473 | |
52 | Ubiquitination | SAGSKANKEFGDSLS CCCHHHHHHHHCHHH | 60.32 | 22817900 | |
61 | Ubiquitination | FGDSLSLEILQIIKE HHCHHHHHHHHHHHH | 37.97 | 24816145 | |
67 | Ubiquitination | LEILQIIKESQQQHG HHHHHHHHHHHHHHC | 53.60 | - | |
77 | Ubiquitination | QQQHGLRHGDFQRYR HHHHCCCCCCHHHHH | 45.26 | 21963094 | |
96 | Ubiquitination | RRQRRLRKTLNFKMG HHHHHHHHHHCCCCC | 63.05 | 24816145 | |
101 | 2-Hydroxyisobutyrylation | LRKTLNFKMGNRHKF HHHHHCCCCCCCCCC | 44.84 | - | |
104 | Ubiquitination | TLNFKMGNRHKFTGK HHCCCCCCCCCCCCC | 39.11 | 21890473 | |
107 | Ubiquitination | FKMGNRHKFTGKKVT CCCCCCCCCCCCCCH | 41.19 | 22817900 | |
111 | Ubiquitination | NRHKFTGKKVTEELL CCCCCCCCCCHHHHH | 40.80 | 22817900 | |
112 | Ubiquitination | RHKFTGKKVTEELLT CCCCCCCCCHHHHHC | 56.59 | 22817900 | |
112 (in isoform 1) | Ubiquitination | - | 56.59 | 21890473 | |
112 (in isoform 2) | Ubiquitination | - | 56.59 | 21890473 | |
113 | Acetylation | HKFTGKKVTEELLTD CCCCCCCCHHHHHCC | 10.43 | 19608861 | |
113 | Ubiquitination | HKFTGKKVTEELLTD CCCCCCCCHHHHHCC | 10.43 | 23000965 | |
118 | Ubiquitination | KKVTEELLTDNRYLL CCCHHHHHCCCCEEE | 6.81 | 23000965 | |
123 | Ubiquitination | ELLTDNRYLLLVLMD HHHCCCCEEEHHHHC | 14.14 | 23000965 | |
126 | Ubiquitination | TDNRYLLLVLMDAER CCCCEEEHHHHCHHH | 2.28 | 29967540 | |
142 | Ubiquitination | WSYAMQLKQEANTEP HHHHHHHHHHHCCCH | 29.24 | 21890473 | |
142 | Ubiquitination | WSYAMQLKQEANTEP HHHHHHHHHHHCCCH | 29.24 | 21890473 | |
142 | Ubiquitination | WSYAMQLKQEANTEP HHHHHHHHHHHCCCH | 29.24 | 21963094 | |
142 (in isoform 1) | Ubiquitination | - | 29.24 | 21890473 | |
142 (in isoform 2) | Ubiquitination | - | 29.24 | 21890473 | |
152 | Ubiquitination | ANTEPRKRFHLLSRL HCCCHHHHHHHHHHH | 26.04 | 22817900 | |
161 | Ubiquitination | HLLSRLRKAVKHAEE HHHHHHHHHHHHHHH | 63.22 | 24816145 | |
164 | Acetylation | SRLRKAVKHAEELER HHHHHHHHHHHHHHH | 41.79 | 27452117 | |
164 | Ubiquitination | SRLRKAVKHAEELER HHHHHHHHHHHHHHH | 41.79 | 29967540 | |
165 | Ubiquitination | RLRKAVKHAEELERL HHHHHHHHHHHHHHH | 31.60 | 27667366 | |
167 | Ubiquitination | RKAVKHAEELERLCE HHHHHHHHHHHHHHH | 63.93 | 21890473 | |
169 | Ubiquitination | AVKHAEELERLCESN HHHHHHHHHHHHHHC | 3.32 | 32015554 | |
177 | Ubiquitination | ERLCESNRVDAKTKL HHHHHHCCCCHHHHH | 36.65 | 23000965 | |
182 | Ubiquitination | SNRVDAKTKLEAQAY HCCCCHHHHHHHHHH | 42.45 | 23000965 | |
185 | Ubiquitination | VDAKTKLEAQAYTAY CCHHHHHHHHHHHHH | 40.05 | 21963094 | |
205 | Ubiquitination | RFEHQEWKAAIEAFN HCCCHHHHHHHHHHH | 27.47 | 21890473 | |
205 | Ubiquitination | RFEHQEWKAAIEAFN HCCCHHHHHHHHHHH | 27.47 | 21890473 | |
205 | Acetylation | RFEHQEWKAAIEAFN HCCCHHHHHHHHHHH | 27.47 | 25953088 | |
205 | Ubiquitination | RFEHQEWKAAIEAFN HCCCHHHHHHHHHHH | 27.47 | 21963094 | |
205 (in isoform 1) | Ubiquitination | - | 27.47 | 21890473 | |
205 (in isoform 2) | Ubiquitination | - | 27.47 | 21890473 | |
210 | Ubiquitination | EWKAAIEAFNKCKTI HHHHHHHHHHHHHHH | 13.75 | 29967540 | |
213 | 2-Hydroxyisobutyrylation | AAIEAFNKCKTIYEK HHHHHHHHHHHHHHH | 30.56 | - | |
213 | Acetylation | AAIEAFNKCKTIYEK HHHHHHHHHHHHHHH | 30.56 | 25953088 | |
213 | Ubiquitination | AAIEAFNKCKTIYEK HHHHHHHHHHHHHHH | 30.56 | 21963094 | |
215 | Ubiquitination | IEAFNKCKTIYEKLA HHHHHHHHHHHHHHH | 39.30 | 23000965 | |
220 | Ubiquitination | KCKTIYEKLASAFTE HHHHHHHHHHHCCCH | 32.17 | 21890473 | |
220 | Ubiquitination | KCKTIYEKLASAFTE HHHHHHHHHHHCCCH | 32.17 | 21890473 | |
220 | Ubiquitination | KCKTIYEKLASAFTE HHHHHHHHHHHCCCH | 32.17 | 23000965 | |
220 (in isoform 1) | Ubiquitination | - | 32.17 | 21890473 | |
220 (in isoform 2) | Ubiquitination | - | 32.17 | 21890473 | |
233 | Phosphorylation | TEEQAVLYNQRVEEI CHHHHHHHHHHHHHC | 11.58 | 28152594 | |
239 | Ubiquitination | LYNQRVEEISPNIRY HHHHHHHHCCCCCCE | 46.00 | 23000965 | |
241 | Phosphorylation | NQRVEEISPNIRYCA HHHHHHCCCCCCEEH | 18.38 | 25159151 | |
247 | Glutathionylation | ISPNIRYCAYNIGDQ CCCCCCEEHHHCCCH | 2.02 | 22555962 | |
250 | Ubiquitination | NIRYCAYNIGDQSAI CCCEEHHHCCCHHHH | 17.16 | 22817900 | |
267 | Phosphorylation | LMQMRLRSGGTEGLL HHHHHHHCCCCCHHH | 46.28 | 30266825 | |
268 | Ubiquitination | MQMRLRSGGTEGLLA HHHHHHCCCCCHHHH | 40.38 | 29967540 | |
270 | Phosphorylation | MRLRSGGTEGLLAEK HHHHCCCCCHHHHHH | 30.33 | 30266825 | |
271 | Ubiquitination | RLRSGGTEGLLAEKL HHHCCCCCHHHHHHH | 51.63 | 24816145 | |
273 | Ubiquitination | RSGGTEGLLAEKLEA HCCCCCHHHHHHHHH | 3.14 | 29967540 | |
277 | Ubiquitination | TEGLLAEKLEALITQ CCHHHHHHHHHHHHH | 46.12 | 21890473 | |
277 | Ubiquitination | TEGLLAEKLEALITQ CCHHHHHHHHHHHHH | 46.12 | 23000965 | |
277 (in isoform 1) | Ubiquitination | - | 46.12 | 21890473 | |
283 | Phosphorylation | EKLEALITQTRAKQA HHHHHHHHHHHHHHC | 25.41 | 21406692 | |
285 | Phosphorylation | LEALITQTRAKQAAT HHHHHHHHHHHHCCC | 24.76 | 21406692 | |
288 | Ubiquitination | LITQTRAKQAATMSE HHHHHHHHHCCCCCC | 36.86 | 22817900 | |
288 (in isoform 1) | Ubiquitination | - | 36.86 | 21890473 | |
294 | Phosphorylation | AKQAATMSEVEWRGR HHHCCCCCCCEECCC | 33.85 | - | |
295 | Ubiquitination | KQAATMSEVEWRGRT HHCCCCCCCEECCCE | 33.36 | 22817900 | |
302 (in isoform 2) | Ubiquitination | - | 31.80 | 21890473 | |
306 | 2-Hydroxyisobutyrylation | RGRTVPVKIDKVRIF CCCEECEEECEEEEE | 38.83 | - | |
306 | Ubiquitination | RGRTVPVKIDKVRIF CCCEECEEECEEEEE | 38.83 | 29967540 | |
309 | Ubiquitination | TVPVKIDKVRIFLLG EECEEECEEEEEEEE | 36.57 | 24816145 | |
318 | Ubiquitination | RIFLLGLADNEAAIV EEEEEECCCCHHHHH | 18.78 | 22817900 | |
322 | Ubiquitination | LGLADNEAAIVQAES EECCCCHHHHHHCCC | 14.56 | 22817900 | |
329 (in isoform 2) | Ubiquitination | - | 43.69 | 21890473 | |
333 | Ubiquitination | QAESEETKERLFESM HCCCHHHHHHHHHHH | 44.08 | 21906983 | |
333 (in isoform 1) | Ubiquitination | - | 44.08 | 21890473 | |
333 (in isoform 2) | Phosphorylation | - | 44.08 | 27642862 | |
334 | Ubiquitination | AESEETKERLFESML CCCHHHHHHHHHHHH | 63.13 | 22817900 | |
339 | Phosphorylation | TKERLFESMLSECRD HHHHHHHHHHHHHHH | 20.07 | - | |
341 (in isoform 2) | Ubiquitination | - | 5.62 | 21890473 | |
344 | Glutathionylation | FESMLSECRDAIQVV HHHHHHHHHHHHHHH | 4.24 | 22555962 | |
356 | Acetylation | QVVREELKPDQKQRD HHHHHHCCCCHHHHC | 50.24 | 26051181 | |
356 | Ubiquitination | QVVREELKPDQKQRD HHHHHHCCCCHHHHC | 50.24 | 22817900 | |
360 | Ubiquitination | EELKPDQKQRDYILE HHCCCCHHHHCHHHC | 55.47 | 21906983 | |
360 (in isoform 1) | Ubiquitination | - | 55.47 | 21890473 | |
362 | Ubiquitination | LKPDQKQRDYILEGE CCCCHHHHCHHHCCC | 45.82 | 24816145 | |
364 | Nitration | PDQKQRDYILEGEPG CCHHHHCHHHCCCCC | 15.03 | - | |
364 | Phosphorylation | PDQKQRDYILEGEPG CCHHHHCHHHCCCCC | 15.03 | 28796482 | |
372 | Ubiquitination | ILEGEPGKVSNLQYL HHCCCCCCCCCHHHH | 53.88 | 22817900 | |
372 (in isoform 1) | Ubiquitination | - | 53.88 | 21890473 | |
378 | Ubiquitination | GKVSNLQYLHSYLTY CCCCCHHHHHHHHHH | 15.00 | 21963094 | |
381 | Phosphorylation | SNLQYLHSYLTYIKL CCHHHHHHHHHHHHH | 21.17 | 28152594 | |
382 | Phosphorylation | NLQYLHSYLTYIKLS CHHHHHHHHHHHHHH | 7.72 | 28152594 | |
384 | Phosphorylation | QYLHSYLTYIKLSTA HHHHHHHHHHHHHHH | 18.24 | 28152594 | |
385 | Phosphorylation | YLHSYLTYIKLSTAI HHHHHHHHHHHHHHH | 8.08 | 28152594 | |
385 (in isoform 2) | Ubiquitination | - | 8.08 | 21890473 | |
400 | Acetylation | KRNENMAKGLQRALL HCCHHHHHHHHHHHH | 49.76 | 27452117 | |
400 | Ubiquitination | KRNENMAKGLQRALL HCCHHHHHHHHHHHH | 49.76 | 24816145 | |
414 | Acetylation | LQQQPEDDSKRSPRP HHCCCCCCCCCCCCH | 55.16 | 19608861 | |
414 | Ubiquitination | LQQQPEDDSKRSPRP HHCCCCCCCCCCCCH | 55.16 | 23000965 | |
415 | Phosphorylation | QQQPEDDSKRSPRPQ HCCCCCCCCCCCCHH | 42.14 | 29255136 | |
416 | Acetylation | QQPEDDSKRSPRPQD CCCCCCCCCCCCHHH | 64.98 | 156451 | |
416 | Ubiquitination | QQPEDDSKRSPRPQD CCCCCCCCCCCCHHH | 64.98 | 21906983 | |
416 (in isoform 1) | Ubiquitination | - | 64.98 | 21890473 | |
418 | Phosphorylation | PEDDSKRSPRPQDLI CCCCCCCCCCHHHHH | 29.06 | 20873877 | |
419 | Ubiquitination | EDDSKRSPRPQDLIR CCCCCCCCCHHHHHH | 56.88 | 23000965 | |
424 | Ubiquitination | RSPRPQDLIRLYDII CCCCHHHHHHHHHHH | 1.75 | 23000965 | |
426 (in isoform 2) | Ubiquitination | - | 34.20 | 21890473 | |
452 | Acetylation | EEDKAFQKEIGLKTL CCCHHHHHHHCHHHH | 44.86 | 19608861 | |
452 | Ubiquitination | EEDKAFQKEIGLKTL CCCHHHHHHHCHHHH | 44.86 | 23000965 | |
453 | Ubiquitination | EDKAFQKEIGLKTLV CCHHHHHHHCHHHHH | 31.35 | 22817900 | |
457 | 2-Hydroxyisobutyrylation | FQKEIGLKTLVFKAY HHHHHCHHHHHHHHH | 34.30 | - | |
457 | Ubiquitination | FQKEIGLKTLVFKAY HHHHHCHHHHHHHHH | 34.30 | 23000965 | |
457 (in isoform 1) | Ubiquitination | - | 34.30 | 21890473 | |
460 (in isoform 2) | Ubiquitination | - | 5.83 | 21890473 | |
462 | Ubiquitination | GLKTLVFKAYRCFFI CHHHHHHHHHHHHHH | 36.71 | 23000965 | |
466 | Ubiquitination | LVFKAYRCFFIAQSY HHHHHHHHHHHHHHH | 1.81 | 27667366 | |
470 | Ubiquitination | AYRCFFIAQSYVLVK HHHHHHHHHHHHHHH | 6.26 | 32015554 | |
473 | Ubiquitination | CFFIAQSYVLVKKWS HHHHHHHHHHHHHHH | 5.92 | 21890473 | |
473 (in isoform 2) | Ubiquitination | - | 5.92 | 21890473 | |
477 | Ubiquitination | AQSYVLVKKWSEALV HHHHHHHHHHHHHHH | 44.35 | - | |
477 (in isoform 2) | Ubiquitination | - | 44.35 | 21890473 | |
486 | Ubiquitination | WSEALVLYDRVLKYA HHHHHHHHHHHHHHH | 8.33 | 21963094 | |
491 | Acetylation | VLYDRVLKYANEVNS HHHHHHHHHHHHHCC | 39.19 | 23236377 | |
491 | Malonylation | VLYDRVLKYANEVNS HHHHHHHHHHHHHCC | 39.19 | 26320211 | |
491 | Ubiquitination | VLYDRVLKYANEVNS HHHHHHHHHHHHHCC | 39.19 | 21906983 | |
491 (in isoform 1) | Ubiquitination | - | 39.19 | 21890473 | |
504 | Ubiquitination | NSDAGAFKNSLKDLP CCCCHHHHHHHHCCC | 45.13 | 21890473 | |
504 | Ubiquitination | NSDAGAFKNSLKDLP CCCCHHHHHHHHCCC | 45.13 | 27667366 | |
504 (in isoform 1) | Ubiquitination | - | 45.13 | 21890473 | |
508 | Acetylation | GAFKNSLKDLPDVQE HHHHHHHHCCCCHHH | 57.97 | 26051181 | |
508 | Ubiquitination | GAFKNSLKDLPDVQE HHHHHHHHCCCCHHH | 57.97 | 22817900 | |
508 (in isoform 1) | Ubiquitination | - | 57.97 | 21890473 | |
511 | Ubiquitination | KNSLKDLPDVQELIT HHHHHCCCCHHHHHH | 50.27 | 29967540 | |
514 | Ubiquitination | LKDLPDVQELITQVR HHCCCCHHHHHHHHH | 47.35 | 21963094 | |
518 | Phosphorylation | PDVQELITQVRSEKC CCHHHHHHHHHHHCC | 33.37 | 20068231 | |
524 | Ubiquitination | ITQVRSEKCSLQAAA HHHHHHHCCCCCHHH | 30.30 | 21963094 | |
541 | Phosphorylation | DANDAHQTETSSSQV CCCCCCCCCCCCHHC | 31.22 | 27251275 | |
543 | Phosphorylation | NDAHQTETSSSQVKD CCCCCCCCCCHHCCC | 36.98 | 27251275 | |
544 | Phosphorylation | DAHQTETSSSQVKDN CCCCCCCCCHHCCCC | 23.04 | 27251275 | |
545 | Phosphorylation | AHQTETSSSQVKDNK CCCCCCCCHHCCCCC | 32.01 | 27251275 | |
546 | Phosphorylation | HQTETSSSQVKDNKP CCCCCCCHHCCCCCC | 38.47 | 27251275 | |
549 | Acetylation | ETSSSQVKDNKPLVE CCCCHHCCCCCCHHH | 48.20 | 25953088 | |
549 | Ubiquitination | ETSSSQVKDNKPLVE CCCCHHCCCCCCHHH | 48.20 | 29967540 | |
552 | Ubiquitination | SSQVKDNKPLVERFE CHHCCCCCCHHHHHH | 50.27 | 21963094 | |
562 | S-nitrosocysteine | VERFETFCLDPSLVT HHHHHHEECCHHHCC | 5.71 | - | |
562 | Glutathionylation | VERFETFCLDPSLVT HHHHHHEECCHHHCC | 5.71 | 22555962 | |
562 | S-nitrosylation | VERFETFCLDPSLVT HHHHHHEECCHHHCC | 5.71 | 19483679 | |
574 | Ubiquitination | LVTKQANLVHFPPGF HCCCCCCCCCCCCCC | 3.38 | 29967540 | |
587 (in isoform 2) | Phosphorylation | - | 39.13 | 27642862 | |
611 | Phosphorylation | EDKLEQKTKSGLTGY HHHHHHHHHCCHHHH | 30.09 | 29978859 | |
612 | Ubiquitination | DKLEQKTKSGLTGYI HHHHHHHHCCHHHHH | 49.95 | 29967540 | |
613 | Phosphorylation | KLEQKTKSGLTGYIK HHHHHHHCCHHHHHH | 44.24 | 29978859 | |
616 | Phosphorylation | QKTKSGLTGYIKGIF HHHHCCHHHHHHHHC | 31.31 | 29978859 | |
618 | Phosphorylation | TKSGLTGYIKGIFGF HHCCHHHHHHHHCCC | 8.33 | 29978859 | |
627 | Phosphorylation | KGIFGFRS------- HHHCCCCC------- | 42.17 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SRP68_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SRP68_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SRP68_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRP72_HUMAN | SRP72 | physical | 22939629 | |
KI21A_HUMAN | KIF21A | physical | 22863883 | |
RL31_HUMAN | RPL31 | physical | 26344197 | |
SRP54_HUMAN | SRP54 | physical | 28514442 | |
SRP19_HUMAN | SRP19 | physical | 28514442 | |
SRP72_HUMAN | SRP72 | physical | 28514442 | |
FZR1_HUMAN | FZR1 | physical | 28514442 | |
SRP14_HUMAN | SRP14 | physical | 28514442 | |
RL26L_HUMAN | RPL26L1 | physical | 28514442 | |
CDC27_HUMAN | CDC27 | physical | 28514442 | |
PUM3_HUMAN | KIAA0020 | physical | 28514442 | |
NOG1_HUMAN | GTPBP4 | physical | 28514442 | |
NOP2_HUMAN | NOP2 | physical | 28514442 | |
CEBPZ_HUMAN | CEBPZ | physical | 28514442 | |
MBB1A_HUMAN | MYBBP1A | physical | 28514442 | |
RBM28_HUMAN | RBM28 | physical | 28514442 | |
RL3_HUMAN | RPL3 | physical | 28514442 | |
EBP2_HUMAN | EBNA1BP2 | physical | 28514442 | |
DDX31_HUMAN | DDX31 | physical | 28514442 | |
TRAP1_HUMAN | TRAP1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-452, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-627, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-618, AND MASSSPECTROMETRY. |